期刊文献+

强化胰岛素治疗对多器官功能障碍综合征患者预后的影响

Effects of intensive insulin therapy on the prognosis of multiple organ dysfunction syndrome patients
下载PDF
导出
摘要 目的观察强化胰岛素治疗对多器官功能障碍综合征(MODS)患者预后的影响。方法选择2005-07~2007-07我院ICU收治的MODS患者65例,随机分成强化胰岛素治疗组(n=31)、常规治疗组(n=34)。强化胰岛素治疗组入院后即给予微量泵泵推胰岛素控制血糖在4.0~6.1mmol/L,常规治疗组血糖控制在10.0~11.0mmol/L,观察两组患者住院病死率、院内感染发生率及机械通气时间。结果强化胰岛素治疗组患者住院病死率、院内感染发生率及机械通气时间均明显低于常规治疗组(P〈0.05)。结论强化胰岛素治疗MODS患者可明显减少并发症,降低病死率,改善预后。 Objective To observe the effects of intensive insulin treatment on the prognosis of multiple organ dysfunction syndrome (MODS) patients. Method From July 2005 to July 2007,65 patients with MODS from Department of Intensive Care Unit ,the Second Hospital of Jilin University were randomly divided into two groups:intensive insulin therapy group( n = 31 ) and control group ( n = 34 ). Inten- sive insulin treatment group received insulin by intravenous injection in order to maintain blood glucose levels at 4.0-6.1 mmol/L,while the control group received routine insulin treatment in order to maintain blood glucose levels at 10.0 - 11.0 mmol/L. The mortality in hospital,incidence of nosocomial infection and time of mechanical ventilation were observed in two groups. Results After the intensive insulin therapy, the mortality in hospital, incidence of nosocomial infection and time of mechanical ventilation were significantly lower than in control group( P 〈 0.05 ). The prognosis of MODS patients was significantly improved. Conclusions Intensive insulin therapy might reduce the complications and mortality, improve the prognosis in the patients of MODS.
出处 《中国急救医学》 CAS CSCD 北大核心 2008年第7期591-593,共3页 Chinese Journal of Critical Care Medicine
关键词 多器官功能障碍综合征 胰岛素 预后 Multiple organ dysfunction syndrome Insulin Prognosis
  • 相关文献

参考文献4

二级参考文献20

  • 1王今达,王宝恩.多脏器功能失常综合征(MODS)病情分期诊断及严重程度评分标准(经庐山’95全国危重病急救医学学术会讨论通过)[J].中国危重病急救医学,1995,7(6):346-347. 被引量:1414
  • 2王今达.90年代多脏衰综合征:SIRS与MODS[J].中国危重病急救医学,1995,7(6):324-328. 被引量:69
  • 3Marshall J C,Cook D J,Christou N V,et al.Multiple organ dysfunction score:a reli able descriptor of a complex clinical outcome[J].Crit Care Med,1995,23:1638-1652.
  • 4Bone R C,Balk R A,Cerra F B,et al.Defi nitions for sepsis and organ failure and guidelines for the use of innovative th erapies in sepsis[J].Chest,1992,101(6):1644-1655.
  • 5Vincent J L,Moreno R,Takala J,et al.The SOFA(sepsis-related organ failure assessment) score to describe organ dysfunction/failure[J] .Intensive Care Med,1996,22:707-710.
  • 6Hallonen K I,Pettila V,Leppaniem A K,et al.Multiple organ dysfunction ass ociated with acute pancreatitis[J].Crit Care Med,2002,30:1274-127 9
  • 7Pettila V,Pettila M,Sarna S,et al.Comparison of multiple organ dysfunctio n scores in the prediction of hospital mortality in the critically ill[J].Cri t Care Med,2002,30(8):1705-1711.
  • 8Angus D C,Linde-Zwirble W T,Lidicker J,et al.Epidemiology of s evere sepsis in the United States:analysis of incidence,outcome,and associat ed costs care[J].Crit Care Med,2001,29(7):1303-1310.
  • 9Weycker D,Akhras K S,Edelsberg J,et al.Long-term mortality and medical care charges in patients with severe sepsis[J].Crit Care Med,2003,31 (9):2316-2323.
  • 10Fry D E,Pearlstein L,Fulton R L,et al.Multiple system organ failure,the role of uncontrolled infection[J].Arch Surg,1980,115(2):136-140.

共引文献1688

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部